NewsBenzingaEditas Medicine: EPS del terzo trimestre $(0,15), supera la stima di $(0,18); vendite a $10,365 milioni, superano la stima di $4,460 milioni Editas Medicine: EPS del terzo trimestre $(0,15), supera la stima di $(0,18); vendite a $10,365 milioni, superano la stima di $4,460 milioni Benzinga 2026.11.09 12:43 (GMT+0) Open on Benzinga Other news How Tokenized Nvidia Traded Through Two Weeks of Huang Headlines What Are Wall Street Analysts' Target Price for Lumentum Holdings Stock? Texas Pacific Land Stock: Analyst Estimates & Ratings Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66